Reducing heart patient readmissions with intentional follow-up care
Using scheduled, intentional touch points for follow-up care, Norton Heart & Vascular Institute is aiming to drive down the readmission rate for heart failure patients and those who’ve had open heart surgery. Mindful that heart […]
View more
Watchman FLX advances over previous version improve safety, efficiency
For patients with atrial fibrillation (A-fib) not caused by a heart valve issue, with at least moderate risk of stroke and issues taking long-term blood thinners, the Watchman device offers an alternative. The left atrial […]
View more
American Heart Association sets standards for heart attack care
If someone is having chest pain, it’s time to get to the best hospital for heart attack treatment. But aren’t all hospitals equipped to treat a heart attack? Yes, and getting treatment right away is […]
View more
Screening and diagnosis of abdominal aortic aneurysm
According to the Society for Vascular Surgery (SVS), 200,000 adults in the U.S. are diagnosed with abdominal aortic aneurysm (AAA) every year. It is the 10th-leading cause of death for American men over the age […]
View more
Hybrid ablation case study: Left ventricular function normalized, medication reduced
The patient A woman presented to Norton Audubon Hospital with shortness of breath and dizziness and was noted to be in new-onset atrial fibrillation (A-fib). She underwent immediate cardioversion but had recurrent A-fib and then […]
View more
Fenestrated endovascular aneurysm repair
While endovascular aneurysm repair (EVAR) of aortic aneurysm has expanded over the last 20 years, there are still cases where this minimally invasive procedure has limitations. Using a new type of endograft called fenestrated endografts, […]
View more
Additional approval makes hybrid ablation available to more atrial fibrillation patients
The Food & Drug Administration (FDA) has approved hybrid ablation as a treatment for long-standing persistent atrial fibrillation (A-fib), the most severe form of the condition affecting about 45% of A-fib patients. Hybrid ablation treats […]
View more
Norton Heart & Vascular Institute using Lux-Dx insertable cardiac monitor with arrhythmia patients
Norton Heart & Vascular Institute is first in the area to adopt the Lux-DX insertable cardiac monitor technology, which reduces the patient’s need for in-person monitoring. Arrhythmia patients of the institute have begun receiving the […]
View more
CHAMPION-AF trial available for A-fib patients in Louisville, Southern Indiana
A new clinical trial, known as CHAMPION-AF, is underway to evaluate the safety and efficacy of the next-generation WATCHMAN FLX left atrial appendage closure (LAAC) device compared with a new generation of blood thinners within […]
View more
A minimally invasive option for mitral regurgitation in high-risk patients
Transcatheter mitral valve repair (TMVr) has been approved by the Food and Drug Administration as a minimally invasive treatment for patients at high risk for conventional surgery. Mitral valve regurgitation sometimes doesn’t need any treatment […]
View more
Nathaniel T. Liu, M.D., leads by example. And analogies.
When vascular surgeon Nathaniel T. Liu, M.D., sees patients, one of his goals is to communicate and help them understand their treatment options. Hearing a doctor explain arterial blockages or how damaged veins are responsible […]
View more
UK HealthCare’s Gill Heart & Vascular Institute expands heart failure, transplant services in collaboration with Norton Heart & Vascular Institute
UK HealthCare (UKHC) and Norton Heart & Vascular Institute are announcing a collaboration to expand advanced heart failure, ventricular assist device (VAD) placement and heart transplant services to Kentuckians. Heart disease is the leading cause […]
View more